Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
about
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tractThe qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaRoutine viral load monitoring versus standard care for reducing morbidity and mortality in adolescent and adult patients living with HIV on antiretroviral therapy (ART)Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapyExamining the relationship between urogenital schistosomiasis and HIV infectionImmunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionA randomized double-blind study of the effect of distant healing in a population with advanced AIDS. Report of a small scale study.A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/mlDiagnosing HIV-related disease: using the CD4 count as a guideContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionClassic AIDS in a sooty mangabey after an 18-year natural infectionFrequent simian foamy virus infection in persons occupationally exposed to nonhuman primatesThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicFavorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNAMonitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimenRole of HLA Adaptation in HIV EvolutionManagement of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapyControlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional CureCrossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledgeImmunovirological parameters and cytokines in HIV infectionThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureInduction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionSIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humansContribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalizationKinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infectionsLarge Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation DynamicsSIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerationsDetection of Dengue Virus Replication in Peripheral Blood Mononuclear Cells from Dengue Virus Type 2-Infected Patients by a Reverse Transcription-Real-Time PCR AssayMolecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practiceInduction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsEpidemiology and interactions of Human Immunodeficiency Virus – 1 and Schistosoma mansoni in sub-Saharan AfricaStructure of the Myristylated Human Immunodeficiency Virus Type 2 Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Membrane TargetingBottlenecks in HIV-1 transmission: insights from the study of founder virusesRole of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replicationAnti-human immunodeficiency virus type 1 (HIV-1) activity of 2'-fluoro-2',3'-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replicationDetection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay
P2860
Q22242981-8EC6A079-A760-4FD3-B4A8-E84D7F39424CQ22248074-4258AA8E-5D71-4884-936D-9FE025E41D21Q24203980-E2E932C8-69B1-4892-A6F3-20016C916C14Q24243499-98D33DCF-5AF0-49FF-9A25-62DDAD0B650FQ24290707-A99F2295-6390-4197-BA7B-7AE261EB9C66Q24531479-8F7E7715-99F8-4D78-BDDA-58A80B10A5AEQ24534187-71186D72-26D6-4915-9025-A25D3855B84DQ24536249-3AF21E23-C397-4B4F-8833-139B43142D8BQ24538481-3B4C3036-97A6-48BC-9B6C-0FC91D99C589Q24545015-2920865F-E736-4C3E-ADC7-74017C37E4FFQ24550654-65C46156-2070-4D37-ADDF-B3B2EFF8E7F2Q24550678-B1B11906-BBC9-4759-8185-ABA560FD2F90Q24563966-3DF3F505-4787-4659-BED5-21F5256A78F0Q24633882-9971A74D-6F1A-43A7-8DAA-A7F78CA073D3Q24655011-2533AF1F-EB60-4946-AF73-21115667D069Q24673636-DC9CA531-6C10-4079-B812-B0AAA73CFC65Q24727667-7AF464DE-BB61-451E-B580-690E68C262A9Q24794051-45560D0E-75DA-4F84-8598-0E6D405A1447Q26772713-573668D7-A441-419E-BD0B-493B4C373453Q26775832-362F8B36-AFB5-49CF-BB4B-09C8DD104A2AQ26781275-7F684094-8BAD-4D40-BC0E-C5B7FF82D0F5Q26824525-51B8F585-65D4-4CCB-8E07-66A35B268831Q26829264-0CF175DB-D56F-428D-85A4-76B74C7116B0Q26864344-0DD0F274-C640-440C-A950-62B26222218EQ27001897-BE83B1C4-3803-4EDF-B394-A8E10C6F6CF1Q27014903-47EB7050-18C2-4183-BC56-733888E1F90FQ27309008-FDA2BE5C-9ADD-4DE3-942C-4F1A8D80C138Q27318045-741DFF3A-A8DD-4B8B-9D7D-BE952D6FD65DQ27333255-FF5D4BAD-6BF2-46D3-A0CC-90133A7728A4Q27339956-2BC98E2B-7570-4D22-8FA3-9CD5979E7D3DQ27340281-868DE935-620F-44AE-B3C9-EDE57DF4F6C3Q27473489-D982AF0B-D393-4062-83C8-684A89C2F0E7Q27477932-4C0125B7-0898-4D8E-8973-2A9B2DFEE121Q27488278-0EAC8B76-B3EF-456E-8F31-B95E0430B20FQ27499293-4E18F8E5-9794-4B94-A957-C8FFD9F61EDAQ27651354-E5689557-3324-40F5-9354-5E280CEA2414Q28082862-581160E6-0365-4120-B516-0C662C91ED2CQ28343594-E4328F4D-B34F-45A4-8A8A-2963667C83B8Q28369925-5B2C4359-E315-4D85-A565-C8BBA8107A34Q28388142-78C07D4A-DE47-4F37-B5D0-CB1FB5C14037
P2860
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@ast
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@en
type
label
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@ast
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@en
prefLabel
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@ast
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@en
P2093
P3181
P1433
P1476
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.272.5265.1167
P407
P577
1996-05-24T00:00:00Z